Skip to content

The effect of caffeine on Chronic Fatigue Syndrome caused by COVID-19

The effect of caffeine on Chronic Fatigue Syndrome caused by COVID-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9bxptps
Enrollment
Unknown
Registered
2022-02-11
Start date
2021-10-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Interventions

Experimental group: 28 survivors of COVID-19 infection with Chronic Fatigue Syndrome will undergo physical and psychological tests, in addition to questionnaires and fatigue scales, with administratio

Sponsors

Universidade Federal de Santa Catarina
Lead Sponsor
Universidade Federal de Santa Catarina
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Have been diagnosed with COVID-19 in the previous period of at least 6 months;Be identified with Chronic Fatigue Syndrome through the International Consensus Criteria; be able to perform physical exercise based on the Physical Activity Readiness Questionnaire (PAR-Q); adult patients (aged 18 years or older); be a consumer of low to moderate amounts of caffeine (200-400mg daily); be literate

Exclusion criteria

Exclusion criteria: Results on the Electrocardiogram that identify incompatibility with the performance of physical exercises; musculoskeletal pathologies that prevent participation; moderate to severe cardiovascular disorders; convulsive history;Gastric problems;Use of nutritional supplements or ergogenic aids; structural or functional deformities;Ischemic or hemorrhagic stroke; arterial hypertension; neurodegenerative diseases; cognitive problems; visual disturbances without treatment; gestation; use of oral contraceptives; color blindness; smoking; use tricyclic antidepressants; use of medications containing caffeine

Design outcomes

Primary

MeasureTime frame
It is expected to find a decrease in persistent symptoms of physical and mental fatigue resulting from Chronic Fatigue Syndrome due to the use of 3mg/kg of caffeine, verified by physical test methods involving cardiorespiratory fitness and muscle strength, psychological test involving concentration and attention and control variables such as heart rate, respiratory rate, blood pressure and oxygen saturation.;It is expected to diagnose the Chronic Fatigue Syndrome through the Myalgic Encephalomyelitis Scale - International Consensus Criteria that describes the symptoms caused by the syndrome.

Secondary

MeasureTime frame
It is expected that volunteers have a significant improvement in quality of life, return to work and activities of daily living, consequently increasing functional independence and decreasing susceptibility to depression due to caffeine treatment. This information will be evaluated through a questionnaire.

Countries

Brazil

Contacts

Public ContactLiziane Cardoso

Universidade Federal de Santa Catarina

lizianecardoso.r@gmail.com+5551993984540

Outcome results

None listed

Source: REBEC (via WHO ICTRP)